Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Resources>White Papers>This White Paper
  White Papers
Scientific News
Food Triggers Creation of Regulatory T Cells
IBS researchers document how normal diet establishes immune tolerance conditions in the small intestine.
Light Signals from Living Cells
Fluorescent protein markers delivered under high pressure.
Counting Cancer-busting Oxygen Molecules
Researchers from the Centre for Nanoscale BioPhotonics (CNBP), an Australian Research Centre of Excellence, have shown that nanoparticles used in combination with X-rays, are a viable method for killing cancer cells deep within the living body.
Therapeutic Approach Gives Hope for Multiple Myeloma
A new therapeutic approach tested by a team from Maisonneuve-Rosemont Hospital (CIUSSS-EST, Montreal) and the University of Montreal gives promising results for the treatment of multiple myeloma, a cancer of the bone marrow currently considered incurable with conventional chemotherapy and for which the average life expectancy is about 6 or 7 years.
Cellular 'Relief Valve'
A team led by scientists at The Scripps Research Institute (TSRI) has solved a long-standing mystery in cell biology by showing essentially how a key “relief-valve” in cells does its job.
Genomic Signature Shared by Five Types of Cancer
National Institutes of Health researchers have identified a striking signature in tumor DNA that occurs in five different types of cancer.
Protein Protects Against Flu in Mice
The engineered molecule doesn’t provoke inflammation and may hail a new class of antivirals.
Cat Stem Cell Therapy Gives Humans Hope
By the time Bob the cat came to the UC Davis veterinary hospital, he had used up most of his nine lives.
Crowdfunding the Fight Against Cancer
From budding social causes to groundbreaking businesses to the next big band, crowdfunding has helped connect countless worthy projects with like-minded people willing to support their efforts, even in small ways. But could crowdfunding help fight cancer?
Switch Lets Salmonella Fight, Evade Immune System
Researchers at the University of Illinois at Chicago have discovered a molecular regulator that allows salmonella bacteria to switch from actively causing disease to lurking in a chronic but asymptomatic state called a biofilm.
Scroll Up
Scroll Down

Approaches to Screening for Risk from Pharmaceuticals in Drinking Water and Prioritization for Further Evaluation
Bookmark and Share


EPA

The presence of pharmaceuticals in drinking water is not a new issue. In the 1970’s, several researchers reported the presence of clofibric acid, a breakdown product of several blood lipid regulators, and salicylic acid, a breakdown product of aspirin, in waste water. However, as analytical techniques grew more sensitive over the years, many more pharmaceuticals have been detected in ambient water, wastewater, and drinking water.

During 1999-2000, the U.S. Geological Survey carried out the first national survey of the occurrence of pharmaceuticals, hormones, and other chemicals in 139 streams from 30 states. A total of 95 contaminants were targeted, with 80 percent of the streams testing positive for one or more contaminants.

Pharmaceuticals enter water through: flushing unused medications down the toilet or sink; excreting unabsorbed medications into the sewage system; farm animals excreting veterinary drugs into fields where they run off into lakes and streams; and commercial improper disposal methods. Conventional water and wastewater treatment methods allow many pharmaceuticals to pass through unchanged, entering the environment and ultimately the drinking water.

One problem with assessing risk of pharmaceuticals in drinking water is the very large number of pharmaceuticals in use today. Information on the occurrence of pharmaceuticals in drinking water is available only for a limited number of compounds. In addition, many pharmaceuticals are biologically degraded to active metabolites that have not been evaluated. One problem with assessing risk of pharmaceuticals in drinking water is the very large number of pharmaceuticals in use today. Information on the occurrence of pharmaceuticals in drinking water is available only for a limited number of compounds. In addition, many pharmaceuticals are biologically degraded to active metabolites that have not been evaluated.

A number of different approaches have been suggested and published in the peer reviewed literature for screening and prioritizing the hazard posed by low concentrations of pharmaceuticals in drinking water. This white paper summarizes and evaluates a number of risk assessment approaches (including EPA’s current approach), that EPA is aware of, that have been described in the literature. This paper is not a comprehensive compilation of all published approaches. In addition, this paper describes EPA’s current activities and research strategy for pharmaceuticals in water.

Further Information

Related Content

Fracking Hasn't Caused Widespread Harm to Water
Assessment shows hydraulic fracturing activities have not led to widespread, systemic impacts to drinking water resources and identifies important vulnerabilities to drinking water resources.
Monday, June 08, 2015
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!